American International Group, Inc. Vertex Pharmaceuticals Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $473,735 - $518,344	-1,162 Reduced 1.19%	96,351 $40.3 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $76,832 - $91,992	-224 Reduced 0.23%	97,513 $39.7 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $919,511 - $985,528	2,719 Added 2.86%	97,737 $34 Million
Q2 2023 Aug 04, 2023	BUY	$314.42 - $351.91 $389,880 - $436,368	1,240 Added 1.32%	95,018 $33.4 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $138,782 - $158,319	490 Added 0.53%	93,778 $29.5 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $1.47 Million - $1.65 Million	-5,141 Reduced 5.22%	93,288 $26.9 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $385,004 - $429,575	-1,406 Reduced 1.41%	98,429 $28.5 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $875,695 - $1.09 Million	-3,727 Reduced 3.6%	99,835 $28.1 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $625,732 - $737,501	-2,826 Reduced 2.66%	103,562 $27 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $377,031 - $475,948	-2,130 Reduced 1.96%	106,388 $23.4 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $154,544 - $172,947	-852 Reduced 0.78%	108,518 $19.7 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $1.49 Million - $1.76 Million	-7,944 Reduced 6.77%	109,370 $22.1 Million
Q1 2021 May 07, 2021	SELL	$207.02 - $241.31 $696,001 - $811,284	-3,362 Reduced 2.79%	117,314 $25.2 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $2.06 Million - $2.74 Million	9,938 Added 8.97%	120,676 $28.5 Million
Q3 2020 Nov 04, 2020	SELL	$255.65 - $303.1 $872,789 - $1.03 Million	-3,414 Reduced 2.99%	110,738 $30.1 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $433,823 - $569,119	1,924 Added 1.71%	114,152 $33.1 Million
Q1 2020 May 04, 2020	SELL	$199.77 - $247.81 $333,216 - $413,347	-1,668 Reduced 1.46%	112,228 $26.7 Million
Q4 2019 Feb 05, 2020	BUY	$166.71 - $223.91 $857,722 - $1.15 Million	5,145 Added 4.73%	113,896 $24.9 Million
Q3 2019 Nov 08, 2019	SELL	$166.23 - $187.09 $34,908 - $39,288	-210 Reduced 0.19%	108,751 $18.4 Million
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $1.2 Million - $1.39 Million	-7,318 Reduced 6.29%	108,961 $20 Million
Q1 2019 May 06, 2019	SELL	$163.73 - $194.7 $94,472 - $112,341	-577 Reduced 0.49%	116,279 $21.4 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $44,965 - $56,894	296 Added 0.25%	116,856 $19.4 Million
Q3 2018 Nov 09, 2018	BUY	$167.73 - $192.74 $931,740 - $1.07 Million	5,555 Added 5.0%	116,560 $22.5 Million
Q2 2018 Aug 08, 2018	BUY	$145.72 - $169.96 $41,384 - $48,268	284 Added 0.26%	111,005 $18.9 Million
Q1 2018 May 07, 2018	BUY	$151.6 - $177.13 $23,346 - $27,278	154 Added 0.14%	110,721 $18 Million
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $319,176 - $361,653	2,325 Added 2.15%	110,567 $16.6 Million
Q3 2017 Nov 09, 2017	BUY	$148.13 - $162.24 $16 Million - $17.6 Million	108,242	108,242 $16.5 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.61 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.33 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account